Single-cell transcriptome analyses reveal microglia types associated with proliferative retinopathy

Zhiping Liu1,2, Huidong Shi3,4, Jiean Xu1

  • 1Vascular Biology Center, Medical College of Georgia, Augusta University, Augusta, Georgia, USA.

JCI Insight
|October 20, 2022
PubMed

Insights

Researchers identified novel proangiogenic microglia subsets driving pathological angiogenesis in proliferative retinopathy (PR). These unique microglia promote retinal neovascularization, offering new therapeutic targets for blindness-causing eye diseases.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Pathological angiogenesis causes irreversible blindness in proliferative retinopathy (PR).
  • Mononuclear phagocytes (MPs) in neovascular areas contribute to aberrant retinal angiogenesis.
  • The cellular heterogeneity of MPs makes it difficult to define specific roles in PR.

Purpose of the Study:

  • Investigate microglia heterogeneity in neovascularization.
  • Characterize transcriptional profiles and metabolic pathways of proangiogenic microglia.
  • Utilize a mouse model of oxygen-induced PR (OIR).

Main Methods:

  • Transcriptional single-cell sorting to map microglia populations.
  • Analysis of microglia in room air (RA) and OIR mouse retinas.
  • Immunohistochemistry (IHC) staining to identify PRAM location.

Main Results:

  • Unveiled unique PR-associated microglia (PRAM) types.
  • Identified markers, signaling pathways, and regulons for PRAM.
  • Discovered proliferative and hypermetabolic microglia subsets expressing glycolytic enzymes and proangiogenic Igf1.

Conclusions:

  • PRAM are spatially located within or around neovascular tufts.
  • These microglia subsets have the potential to promote retinal angiogenesis.
  • Findings have implications for treating PR and other pathological ocular angiogenesis diseases.

Related Concept Videos